The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy

Junyu Deng,1 Ye Liu,1 Yiqiu Liu,1 Wei Li,1,2 Xuqiang Nie1– 4 1College of Pharmacy, Zunyi Medical University, Zunyi, 563000, People’s Republic of China; 2Joint International Research Laboratory of Ethnomedicine of Chinese Ministry of Education, Zunyi Medical University, Zunyi, 563000, People’s Republ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Deng J, Liu Y, Li W, Nie X
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/3f88572e43d34505b3fb5060f20cb095
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3f88572e43d34505b3fb5060f20cb095
record_format dspace
spelling oai:doaj.org-article:3f88572e43d34505b3fb5060f20cb0952021-12-02T19:21:04ZThe Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy1178-7031https://doaj.org/article/3f88572e43d34505b3fb5060f20cb0952021-10-01T00:00:00Zhttps://www.dovepress.com/the-multiple-roles-of-fibroblast-growth-factor-in-diabetic-nephropathy-peer-reviewed-fulltext-article-JIRhttps://doaj.org/toc/1178-7031Junyu Deng,1 Ye Liu,1 Yiqiu Liu,1 Wei Li,1,2 Xuqiang Nie1– 4 1College of Pharmacy, Zunyi Medical University, Zunyi, 563000, People’s Republic of China; 2Joint International Research Laboratory of Ethnomedicine of Chinese Ministry of Education, Zunyi Medical University, Zunyi, 563000, People’s Republic of China; 3Key Laboratory of the Basic Pharmacology of the Ministry of Education, Zunyi Medical University, Zunyi, 563000, People’s Republic of China; 4Institute of Materia Medica, College of Pharmacy, Third Military Medical University (Army Medical University), Chongqing, 400038, People’s Republic of ChinaCorrespondence: Xuqiang NieCollege of Pharmacy, Joint International Research Laboratory of Ethnomedicine of Chinese Ministry of Education, Zunyi Medical University, Zunyi, 563000, People’s Republic of ChinaTel +86-0851-2864-2516Email niexuqiang@zmu.edu.cnAbstract: Diabetic nephropathy (DN) is a common microvascular complication in the late stages of diabetes. Currently, the etiology and pathogenesis of DN are not well understood. Even so, available evidence shows its development is associated with metabolism, oxidative stress, cytokine interaction, genetic factors, and renal microvascular disease. Diabetic nephropathy can lead to proteinuria, edema and hypertension, among other complications. In severe cases, it can cause life-threatening complications such as renal failure. Patients with type 1 diabetes, hypertension, high protein intake, and smokers have a higher risk of developing DN. Fibroblast growth factor (FGF) regulates several human processes essential for normal development. Even though FGF has been implicated in the pathological development of DN, the underlying mechanisms are not well understood. This review summarizes the role of FGF in the development of DN. Moreover, the association of FGF with metabolism, inflammation, oxidative stress and fibrosis in the context of DN is discussed. Findings of this review are expected to deepen our understanding of DN and generate ideas for developing effective prevention and treatments for the disease.Keywords: fibroblast growth factor, diabetic nephropathy, signaling pathways, pharmacological action, renal fibrosisDeng JLiu YLiu YLi WNie XDove Medical Pressarticlefibroblast growth factordiabetic nephropathysignaling pathwayspharmacological actionrenal fibrosisPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 5273-5290 (2021)
institution DOAJ
collection DOAJ
language EN
topic fibroblast growth factor
diabetic nephropathy
signaling pathways
pharmacological action
renal fibrosis
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
spellingShingle fibroblast growth factor
diabetic nephropathy
signaling pathways
pharmacological action
renal fibrosis
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Deng J
Liu Y
Liu Y
Li W
Nie X
The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
description Junyu Deng,1 Ye Liu,1 Yiqiu Liu,1 Wei Li,1,2 Xuqiang Nie1– 4 1College of Pharmacy, Zunyi Medical University, Zunyi, 563000, People’s Republic of China; 2Joint International Research Laboratory of Ethnomedicine of Chinese Ministry of Education, Zunyi Medical University, Zunyi, 563000, People’s Republic of China; 3Key Laboratory of the Basic Pharmacology of the Ministry of Education, Zunyi Medical University, Zunyi, 563000, People’s Republic of China; 4Institute of Materia Medica, College of Pharmacy, Third Military Medical University (Army Medical University), Chongqing, 400038, People’s Republic of ChinaCorrespondence: Xuqiang NieCollege of Pharmacy, Joint International Research Laboratory of Ethnomedicine of Chinese Ministry of Education, Zunyi Medical University, Zunyi, 563000, People’s Republic of ChinaTel +86-0851-2864-2516Email niexuqiang@zmu.edu.cnAbstract: Diabetic nephropathy (DN) is a common microvascular complication in the late stages of diabetes. Currently, the etiology and pathogenesis of DN are not well understood. Even so, available evidence shows its development is associated with metabolism, oxidative stress, cytokine interaction, genetic factors, and renal microvascular disease. Diabetic nephropathy can lead to proteinuria, edema and hypertension, among other complications. In severe cases, it can cause life-threatening complications such as renal failure. Patients with type 1 diabetes, hypertension, high protein intake, and smokers have a higher risk of developing DN. Fibroblast growth factor (FGF) regulates several human processes essential for normal development. Even though FGF has been implicated in the pathological development of DN, the underlying mechanisms are not well understood. This review summarizes the role of FGF in the development of DN. Moreover, the association of FGF with metabolism, inflammation, oxidative stress and fibrosis in the context of DN is discussed. Findings of this review are expected to deepen our understanding of DN and generate ideas for developing effective prevention and treatments for the disease.Keywords: fibroblast growth factor, diabetic nephropathy, signaling pathways, pharmacological action, renal fibrosis
format article
author Deng J
Liu Y
Liu Y
Li W
Nie X
author_facet Deng J
Liu Y
Liu Y
Li W
Nie X
author_sort Deng J
title The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
title_short The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
title_full The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
title_fullStr The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
title_full_unstemmed The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
title_sort multiple roles of fibroblast growth factor in diabetic nephropathy
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/3f88572e43d34505b3fb5060f20cb095
work_keys_str_mv AT dengj themultiplerolesoffibroblastgrowthfactorindiabeticnephropathy
AT liuy themultiplerolesoffibroblastgrowthfactorindiabeticnephropathy
AT liuy themultiplerolesoffibroblastgrowthfactorindiabeticnephropathy
AT liw themultiplerolesoffibroblastgrowthfactorindiabeticnephropathy
AT niex themultiplerolesoffibroblastgrowthfactorindiabeticnephropathy
AT dengj multiplerolesoffibroblastgrowthfactorindiabeticnephropathy
AT liuy multiplerolesoffibroblastgrowthfactorindiabeticnephropathy
AT liuy multiplerolesoffibroblastgrowthfactorindiabeticnephropathy
AT liw multiplerolesoffibroblastgrowthfactorindiabeticnephropathy
AT niex multiplerolesoffibroblastgrowthfactorindiabeticnephropathy
_version_ 1718376730349010944